Stress echocardiogaphy: a useful test for assessing cardiac risk in diabetes.
Cardiovascular disease is the leading cause of death in patients with diabetes therefore prompt diagnosis and treatment of high risk groups is essential. Dobutamine stress echocardiography is a safe, cheap and reliable method for coronary artery disease diagnosis and provides important long term prognostic information. The diagnostic accuracy and prognostic power of this technique has been validated by a number of studies on patients with and without diabetes. This article discusses the application, interpretation, and accuracy of stress echocardiography both in the general population and in patients with diabetes. The role of advanced imaging modalites such as myocardial contrast agents and tissue Doppler imaging is also explored.
Ealing Hospital, London, UK. raj.sharma@eht.nhs.uk
Rajan
R
Sharma
Denis
D
Pellerin
D003287:Contrast Media; D003326:Coronary Circulation; D048909:Diabetes Complications / Q000000981:diagnostic imaging* / Q000503:physiopathology; D004280:Dobutamine; D015150:Echocardiography, Doppler; D025401:Echocardiography, Stress / Q000379:methods; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging* / Q000503:physiopathology; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D018570:Risk Assessment; D014665:Vasodilator Agents
D003287:Contrast Media; D014665:Vasodilator Agents; D004280:Dobutamine